| Literature DB >> 31591369 |
Ming-Lung Chuang1,2, I-Feng Lin3, Meng-Jer Hsieh4,5.
Abstract
Patients with chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF) often have dyspnea. Despite differences in primary organ derangement and similarities in secondary skeletal muscle changes, both patient groups have prominent functional impairment. With similar daily exercise performance in patients with CHF and COPD, we hypothesized that patients with CHF would have worse ventilatory muscle oxygenation than patients with COPD. This study aimed to compare differences in tissue oxygenation and blood capacity between ventilatory muscles and leg muscles and between the two patient groups. Demographic data, lung function, and maximal cardiopulmonary exercise tests were performed in 134 subjects without acute illnesses. Muscle oxygenation and blood capacity were measured using frequency-domain near-infrared spectroscopy (fd-NIRS). We enrolled normal subjects and patients with COPD and CHF. The two patient groups were matched by oxygen-cost diagram scores, New York Heart Association functional classification scores, and modified Medical Research Council scores. COPD was defined as forced expired volume in one second and forced expired vital capacity ratio ≤0.7. CHF was defined as stable heart failure with an ejection fraction ≤49%. The healthy subjects were defined as those with no obvious history of chronic disease. Age, body mass index, cigarette consumption, lung function, and exercise capacity were different across the three groups. Muscle oxygenation and blood capacity were adjusted accordingly. Leg muscles had higher deoxygenation (HHb) and oxygenation (HbO2) and lower oxygen saturation (SmO2) than ventilatory muscles in all participants. The SmO2 of leg muscles was lower than that of ventilatory muscles because SmO2 was calculated as HbO2/(HHb+HbO2), and the HHb of leg muscles was relatively higher than the HbO2 of leg muscles. The healthy subjects had higher SmO2, the patients with COPD had higher HHb, and the patients with CHF had lower HbO2 in both muscle groups throughout the tests. The patients with CHF had lower SmO2 of ventilatory muscles than the patients with COPD at peak exercise (p < 0.01). We conclud that fd-NIRS can be used to discriminate tissue oxygenation of different musculatures and disease entities. More studies on interventions on ventilatory muscle oxygenation in patients with CHF and COPD are warranted.Entities:
Keywords: cardiopulmonary exercise testing; chronic obstructive pulmonary disease; frequency domain; heart failure; maximal exercise; near-infrared spectroscopy; serratus anterior muscle; vastus lateralis muscle
Year: 2019 PMID: 31591369 PMCID: PMC6832638 DOI: 10.3390/jcm8101641
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1An image of flow diagram. A total of 175 subjects were screened and 134 patients were enrolled and analyzed. Follow-up was not applicable in this study.
Demographic data, symptom scores, lung function and oxyhemoglobin saturation measured with pulse oximetry (SPO2) and oxygen uptake (VO2) at rest.
| Group | Normal | COPD | CHF | ANOVA | |||
|---|---|---|---|---|---|---|---|
| mean | SD | mean | SD | mean | SD | ||
| 37 | 77 | 20 | |||||
| Age, years | 54.5 | 17.5 | 66.4 | 11.1 | 52.1 | 12.6 | <0.0001 |
| Gender, M/F | 33/4 | 70/7 | 19/1 | 0.76 | |||
| Body mass index, kg/cm2 | 23.8 | 3.0 | 24.0 | 3.7 | 26.3 | 3.1 | <0.05 |
| Oxygen-cost diagram, cm | 8.6 | 1.2 | 7.0 | 1.2 | 7.6 | 1 | <0.0001 |
| NYHAfc, I, II, III (%) | - | 37.9, 51.7, 10.3 | 47.1, 52.9, 0 | 0.58 | |||
| mMRC, 0, 1, 2 (%) | - | 41.4, 48.3, 10.3 | 70.6, 29.4, 0 | 0.14 | |||
| Cigarette, pack⋅year | 4.8 | 17.5 | 58 | 33.2 | 31.8 | 26 | <0.0001 |
| Co-morbidity, Yes/No | |||||||
| Hypertension, | 4/36 * | 18/73 * | 11/20 | <0.01 | |||
| Diabetes mellitus, | 1/36 * | 6/73 * | 1/20 | 0.57 | |||
| Lung function and others | |||||||
| FVC %predicted, % | 96 | 12 | 76 | 21 | 88 | 14 | <0.0001 |
| FEV1%predicted, % | 97 | 10 | 59 | 22 | 88 | 14 | <0.0001 |
| FEV1/FVC ratio, % | 81 | 7 | 59 | 15 | 82 | 5 | <0.0001 |
| Ejection fraction †, % | - | - | - | - | 44 | 7 | NA |
| 17 | 5 | 22 | 8 | 18 | 6 | <0.01 | |
| SPO2, % | 97 | 1 | 96 | 3 | 97 | 1 | <0.001 |
COPD: chronic obstructive pulmonary disease, CHF: congestive heart failure. FVC: forced expired capacity, NYHAfc: New York Heart Association functional classification, mMRC: modified Medical Research Council, FEV1: forced expired volume in one second, * missing one and four subjects, respectively. Participants with CHF included 1 subject with ventricular septal defect, 2 subjects waiting for heart transplantations, 3 subjects with decompensated cardiomyopathy, 13 subjects with coronary artery disease, and 1 subject with hypertensive cardiovascular disease. † Ejection fraction of the left ventricle using 2-dimensional echocardiography.
Cardiopulmonary exercise test at peak exercise.
| Group | Normal | COPD | CHF | ANOVA | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| mean | SD | mean | SD | mean | SD | ||||||||||
| Workload, WR, watt | 144 | 32 | 87 | 40 | 116 | 28 | 0.0002 | ||||||||
| WR, watt% predicted, (% | 107 | 26 | 78 | 27 | 81 | 27 | 0.42 | ||||||||
| Respiratory exchange ratio | 1.11 | 0.16 | 1.11 | 0.16 | 1.17 | 0.13 | 0.62 | ||||||||
| Oxygen uptake, | 81 | 8 | 68 | 22 | 60 | 16 | 0.07 | ||||||||
| 30.4 | 4 | 17.6 | 6.3 | 18.4 | 2.6 | <0.0001 | |||||||||
| 48 | 8 | 49 | 9 | 37 | 11 | 0.07 | |||||||||
| Cardiac frequency, fc, % | 91 | 5 | 84 | 9 | 84 | 15 | 0.11 | ||||||||
| 11 | 2 | 9 | 3 | 8 | 2 | 0.09 | |||||||||
| Systolic blood pressure, mm Hg | 193 | 17 | 175 | 22 | 150 | 30 | 0.008 | ||||||||
| Diastolic blood pressure, mm Hg | 80 | 5 | 86 | 12 | 87 | 21 | 0.82 | ||||||||
| Minute ventilation, | 59.4 | 12.5 | 43.7 | 17 | 61.7 | 18.9 | 0.002 | ||||||||
| Breathing frequency, b/min | 32 | 6 | 37 | 7 | 43 | 8 | 0.01 | ||||||||
| Tidal volume, VT, L | 1.88 | 0.36 | 0.98 | 0.45 | 1.32 | 0.36 | <0.0001 | ||||||||
| VT peak/vital capacity | 0.5 | 0.06 | 0.47 | 0.1 | 0.45 | 0.09 | 0.46 | ||||||||
| 0.45 | 0.11 | 0.75 | 0.22 | 0.56 | 0.12 | 0.0001 | |||||||||
| 30.1 | 5 | 37.1 | 5.9 | 37.7 | 3.9 | 0.002 | |||||||||
| SPO2, % | 94.6 | 4 | 92.9 | 4.5 | 98.3 | 1.1 | 0.009 | ||||||||
| Borg dyspnea at peak | NA | NA | 6.1 | 1.5 | 4.8 | 1.3 | 0.05 | ||||||||
COPD: chronic obstructive pulmonary disease, CHF: congestive heart failure, SPO2: oxyhemoglobin saturation measured with pulse oximetry.
Figure 2Tissue deoxygenation (HHb, row (A)), oxygenation (HbO2, row (B)), total blood capacity (TOT, row (C)), and saturation (SmO2, row (D)) of leg muscles (solid symbol) and ventilatory muscles (open symbol) in response to incremental exercise in healthy subjects (Normal) and subjects with chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF). Paired t tests were used for comparison between two muscles at three stages of the exercise test, respectively: a p < 0.05, b p < 0.01, c p < 0.001, d p < 0.0001; paired t tests were used for comparisons of changes in variables between rest and unloaded exercise and between unloaded exercise and at peak (or nadir) exercise, respectively: # p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001, + p < 0.0001.
Figure 3Tissue deoxygenation (HHb, row (A)), oxygenation (HbO2, row (B)), total blood capacity (TOT, row (C)), and saturation (SmO2, row (D)) of leg muscles (left panels, solid symbols) and ventilatory muscles (right panels, open symbols) in response to incremental exercise in healthy subjects (square symbol) and subjects with chronic obstructive pulmonary disease (COPD, circle symbol) and congestive heart failure (CHF, down triangle symbol). ANOVA was used for group comparisons at 3 stages of exercise, respectively: q p < 0.1, a p < 0.05, b p < 0.01, c p < 0.001, d p < 0.0001; Paired t tests were used for comparisons of changes in variables between rest and unloaded exercise and between unloaded exercise and at peak (or nadir) exercise, respectively: # p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001, + p < 0.0001. Comparisons of variables between two groups of subjects, Arabic numbers 5 p < 0.1, 1 p < 0.05, 2 p < 0.01, 3 p < 0.001, 4 p < 0.0001.
Correlation coefficient (r) of oxygenation saturation of muscles at peak exercise with demographics, lung function and peak/nadir exercise in all subjects.
| Demographics | Vastus Lateralis ( | Serratus Anterior ( |
|---|---|---|
| Age | − | − |
| OCD |
|
|
| Cigarette | −0.13 | − |
| BMI | 0.21 ¶ | 0.23 ¶ |
| Lung function | ||
| MIP% |
|
|
| MEP% | 0.07 | 0.14 |
| FVC% | −0.03 | −0.13 |
| FEV1% | 0.12 | 0.11 |
| FEV1/FVC | 0.24 ¶ | 0.11 |
| Exercise | ||
| HR |
|
|
| Watt% | −0.02 | 0.02 |
| VO2% | −0.08 | 0.03 |
| VO2/HR | 0.01 | 0.13 |
| dVO2/dWR | 0.07 | 0.05 |
| VE% | − | − |
| VE/VCO2 | − | −0.21 |
| Borg | − | −0.15 |
| SPO2 |
| 0.04 |
| VT/VC | −0.09 | −0.13 |
| Bf | 0.03 | −0.08 |
OCD: oxygen-cost diagram, Cigarette: in pack × years, BMI: body mass index, MIP: maximal inspiratory pressure, MEP: maximal expiratory pressure, FVC: forced vital capacity, FEV1: forced expired volume in one second, HR: heart rate, d: slope, VO2: oxygen uptake, VE: minute ventilation, WR: work rate, VCO2: ratio of VE and carbon dioxide output, SPO2: oxyhemoglobin measured by pulse oximetry, VT/VC: ratio of tidal volume and vital capacity, Bf: breathing frequency. The numbers in bold indicate p < 0.05. ¶ 0.05 < p < 0.1, * p < 0.05, ** p < 0.01, † p < 0.001, †† p < 0.0001.